Bridget E. Bunner

Array ( [id] => 7251826 [patent_doc_number] => 20040259110 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Gene PRV-1 and its use' [patent_app_type] => new [patent_app_number] => 10/727619 [patent_app_country] => US [patent_app_date] => 2003-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4982 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20040259110.pdf [firstpage_image] =>[orig_patent_app_number] => 10727619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7473801 [patent_doc_number] => 20040121960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Peptide analogs and mimetics suitable for in vivo use in the treatment of diseases associated with abnormal protein folding into amyloid, amyloid like deposits or beta sheet rich pathological precursor thereof' [patent_app_type] => new [patent_app_number] => 10/726366 [patent_app_country] => US [patent_app_date] => 2003-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7569 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20040121960.pdf [firstpage_image] =>[orig_patent_app_number] => 10726366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 899710 [patent_doc_number] => 07338799 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-04 [patent_title] => 'Polynucleotide encoding a mouse choline transporter' [patent_app_type] => utility [patent_app_number] => 10/724806 [patent_app_country] => US [patent_app_date] => 2003-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 50855 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/338/07338799.pdf [firstpage_image] =>[orig_patent_app_number] => 10724806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7676952 [patent_doc_number] => 20040152874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'Transporter and ion channels' [patent_app_type] => new [patent_app_number] => 10/478758 [patent_app_country] => US [patent_app_date] => 2003-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46868 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20040152874.pdf [firstpage_image] =>[orig_patent_app_number] => 10478758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7361941 [patent_doc_number] => 20040091497 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Schizophrenia-related voltage-gated ion channel gene and protein' [patent_app_type] => new [patent_app_number] => 10/433580 [patent_app_country] => US [patent_app_date] => 2003-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 70641 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20040091497.pdf [firstpage_image] =>[orig_patent_app_number] => 10433580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7345252 [patent_doc_number] => 20040247564 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Regeneration of endogenous myocardial tissue' [patent_app_type] => new [patent_app_number] => 10/693480 [patent_app_country] => US [patent_app_date] => 2003-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 31084 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20040247564.pdf [firstpage_image] =>[orig_patent_app_number] => 10693480 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7351699 [patent_doc_number] => 20040048273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-11 [patent_title] => 'Regulation of human secretin receptor-like gpcr' [patent_app_type] => new [patent_app_number] => 10/398454 [patent_app_country] => US [patent_app_date] => 2003-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 28287 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20040048273.pdf [firstpage_image] =>[orig_patent_app_number] => 10398454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6905528 [patent_doc_number] => 20050100923 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Compositions, methods, and kits useful for the diagnosis and treatment of spinal muscular atrophy' [patent_app_type] => utility [patent_app_number] => 10/677662 [patent_app_country] => US [patent_app_date] => 2003-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 56 [patent_no_of_words] => 63035 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20050100923.pdf [firstpage_image] =>[orig_patent_app_number] => 10677662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7555466 [patent_doc_number] => 08067367 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-29 [patent_title] => 'Methods of increasing platelet and hematopoietic stem cell production' [patent_app_type] => utility [patent_app_number] => 10/667096 [patent_app_country] => US [patent_app_date] => 2003-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8411 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/067/08067367.pdf [firstpage_image] =>[orig_patent_app_number] => 10667096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 572751 [patent_doc_number] => 07459308 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-02 [patent_title] => 'Nucleic acid molecule encoding a CLASP-2 transmembrane protein' [patent_app_type] => utility [patent_app_number] => 10/663538 [patent_app_country] => US [patent_app_date] => 2003-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 88 [patent_figures_cnt] => 26 [patent_no_of_words] => 51471 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/459/07459308.pdf [firstpage_image] =>[orig_patent_app_number] => 10663538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7393481 [patent_doc_number] => 20040038285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Novel polypeptides, cDNA encoding the same and utilization thereof' [patent_app_type] => new [patent_app_number] => 10/657103 [patent_app_country] => US [patent_app_date] => 2003-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9561 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20040038285.pdf [firstpage_image] =>[orig_patent_app_number] => 10657103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6990921 [patent_doc_number] => 20050089958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Apo-2 ligand' [patent_app_type] => utility [patent_app_number] => 10/652979 [patent_app_country] => US [patent_app_date] => 2003-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 27169 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20050089958.pdf [firstpage_image] =>[orig_patent_app_number] => 10652979 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7234608 [patent_doc_number] => 20040157326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-12 [patent_title] => 'Promoters of the growth and/or differentiation of hematopoietic stem cells and/or hematopoietic progenitors' [patent_app_type] => new [patent_app_number] => 10/649952 [patent_app_country] => US [patent_app_date] => 2003-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14585 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20040157326.pdf [firstpage_image] =>[orig_patent_app_number] => 10649952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7230473 [patent_doc_number] => 20050079151 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-14 [patent_title] => 'Therapeutic agents for apoptosis-related diseases' [patent_app_type] => utility [patent_app_number] => 10/641728 [patent_app_country] => US [patent_app_date] => 2003-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 8616 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20050079151.pdf [firstpage_image] =>[orig_patent_app_number] => 10641728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8282482 [patent_doc_number] => 08216583 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-10 [patent_title] => 'Formulation of human antibodies for treating TNF-α associated disorders' [patent_app_type] => utility [patent_app_number] => 10/525292 [patent_app_country] => US [patent_app_date] => 2003-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13505 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 264 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10525292 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 411113 [patent_doc_number] => 07282208 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-16 [patent_title] => 'Method for stimulating wound healing' [patent_app_type] => utility [patent_app_number] => 10/623567 [patent_app_country] => US [patent_app_date] => 2003-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6329 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/282/07282208.pdf [firstpage_image] =>[orig_patent_app_number] => 10623567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 168770 [patent_doc_number] => 07666982 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-23 [patent_title] => 'Notch-origin polypeptides and biomarkers and reagents using the same' [patent_app_type] => utility [patent_app_number] => 10/521691 [patent_app_country] => US [patent_app_date] => 2003-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 29 [patent_no_of_words] => 7387 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/666/07666982.pdf [firstpage_image] =>[orig_patent_app_number] => 10521691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7239619 [patent_doc_number] => 20050080250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-14 [patent_title] => 'Methods of stimulating growth of stromal cells in a human' [patent_app_type] => utility [patent_app_number] => 10/620642 [patent_app_country] => US [patent_app_date] => 2003-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 119 [patent_figures_cnt] => 119 [patent_no_of_words] => 52070 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0080/20050080250.pdf [firstpage_image] =>[orig_patent_app_number] => 10620642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5655825 [patent_doc_number] => 20060141561 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Apo-2 ligand/trail variants and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/519647 [patent_app_country] => US [patent_app_date] => 2003-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 29470 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20060141561.pdf [firstpage_image] =>[orig_patent_app_number] => 10519647 [rel_patent_id] =>[rel_patent_doc_number] =>)